Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia

Journal of Infection

Volumn 59, Issue 4, 2009, Pages 277-280

  Rodriguez, Carlos A ^a   Agudelo, Maria ^a   Cataño, Juan C ^a   Zuluaga, Andres F ^a   Vesga, Omar ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Generic drugs; Staphylococcus aureus; Therapeutic equivalency; Vancomycin

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; GENERIC DRUG; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OXACILLIN; PENICILLIN G; PREDNISONE; TACROLIMUS; VANCOMYCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL PERITONITIS; BACTERIOSTASIS; BIOEQUIVALENCE; BLOOD CULTURE; CASE REPORT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMATOMA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLEURA EFFUSION; RECIPIENT; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUGS, GENERIC; HUMANS; LIVER TRANSPLANTATION; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 72049120130     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.08.005     Document Type: Article

References (15)

1. Sakoulas G., Moise-Broder P.A., Schentag J.J., Forrest A., Moellering Jr. R.C., and Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42 6 (2004) 2398-2402
2. Cantoni L., Glauser M.P., and Bille J. Comparative efficacy of daptomycin, vancomycin and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Antimicrob Agents Chemother 34 12 (1990) 2348-2353
3. Small P.M., and Chambers H.F. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34 (1990) 1227-1231
4. Iwahara T., Ichiyama S., Nada T., Shimokata K., and Nakashima N. Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin resistant Staphylococcus aureus. Chest 105 (1994) 826-831
5. Moise P.A., and Schentag J.J. Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents 16 Suppl 1 (2000) S31-S34
6. Howden B.P., Ward P.B., Charles G.P., et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38 (2004) 521-528
7. Vesga O. Generics and generics. [Abstract 1338]. Program and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (December 16-19, 2005), American Society for Microbiology, Washington, D.C
8. James C.W., and Gurk-Turner C. Recommendations for monitoring serum vancomycin concentrations. BUMC Proceedings 14 (2001) 189-190
9. Hiramatsu K., Hanaki H., Ino T., Yabuka K., Oguri T., and Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40 (1997) 135-136
10. Zuluaga A.F., Salazar B.E., Rodriguez C.A., Zapata A.X., Agudelo M., and Vesga O. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect Dis 6 (2006 March 17) 55
11. Lamy P.P. Generic equivalence: issues and concerns. J Clin Pharmacol 26 (1986) 309-316
12. Welage L.S., Kirking D.M., Ascione F.J., and Gaither C.A. Understanding the scientific issues embedded in the generic drug approval process. J Am Pharm Assoc 41 (2001) 856-867
13. Kim S.H., Kim K.H., Kim H.B., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 52 1 (2008 Jan) 192-197
14. Kirby W.M. Vancomycin therapy in severe staphylococcal infections. Rev Infect Dis 3 Suppl (1981) S236-S239
15. Levine D.P. Vancomycin: a history. Clin Infect Dis 42 (2006) S5-S12